ÀÓ»ó½ÃÇè ½ÃÀåÁ¶»çº¸°í¼­

ÀÓ»ó½ÃÇè ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 1,321°Ç)
ÀüÀÓ»ó CRO ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ¼­ºñ½º(µ¶¼º ½ÃÇè, »ýºÐ¼®, DMPK ¿¬±¸), ÃÖÁ¾»ç¿ëÀÚ(¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷, Á¤ºÎ ¹× Çмú±â°ü), Áö¿ªº° ¿¹Ãø(2021-2028³â)
Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 - 2028
¹ßÇà 2021³â 02¿ù
°¡°Ý US $ 5,950 £Ü 6,791,000
ÀÚ±ÃÆòȰ±ÙÁ¾(ÀڱñÙÁ¾) : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Uterine Leiomyoma (Uterine Fibroids) Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 02¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
¼¼°èÀÇ ÀüÀÓ»ó CRO ½ÃÀå(2021-2027³â) : ½ÃÀå ¿¹Ãø(¼­ºñ½º, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°), ¾÷°è µ¿Çâ, Áö¿ª Àü¸Á, ÀÀ¿ë ÀáÀ缺, °¡°Ý µ¿Çâ, ½ÃÀå Á¡À¯À²
Preclinical CRO Market Size By Service, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
¹ßÇà 2021³â 02¿ù
°¡°Ý US $ 5,150 £Ü 5,878,000
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¿ëǰ ½ÃÀå : ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2020-2027³â)
Global Clinical Trial Supplies Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027
¹ßÇà 2021³â 02¿ù
°¡°Ý US $ 2,100 £Ü 2,396,000
¼¼°èÀÇ eCOA(Electronic Clinical Outcome Assessment) ¼Ö·ç¼Ç ½ÃÀå : µô¸®¹ö¸® ¸ðµåº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¼ºÀå, µ¿Çâ, ¿¹Ãø(2018-2023³â)
Electronic Clinical Outcome Assessment Solutions (eCOA) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
¹ßÇà 2021³â 02¿ù
°¡°Ý US $ 4,250 £Ü 4,850,000
¼¼°èÀÇ ÀÓ»ó½ÃÇè °ü¸® ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø(-2025³â) : Á¦Ç°(¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º), Àü°³ ¹æ½Ä(À¥, ¿ÂÇÁ·¹¹Ì½º, Ŭ¶ó¿ìµå), µµÀÔ(¿£ÅÍÇÁ¶óÀÌÁî, ¿Â»çÀÌÆ®), ÃÖÁ¾»ç¿ëÀÚ(Á¦¾à, ÀÇ·á±â±â Á¦Á¶¾÷ü, CRO), Áö¿ªº°
Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) - Global Forecasts to 2025
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 4,950 £Ü 5,649,000
ºñ¾ËÄڿüº Áö¹æ°£¿°(NASH) ½ÃÀå°ú ºÐ¼® ¿¹Ãø(-2038³â)
Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 22,000 £Ü 25,110,000
Valrox(Valoctocogene Roxaparvovec) : ½Å¾à ÀλçÀÌÆ®¿Í ½ÃÀå ¿¹Ãø(2030³â)
Valrox (Valoctocogene Roxaparvovec)- Emerging Drug Insight and Market Forecast - 2030
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 3,250 £Ü 3,709,000
ÀÚ°£ÀüÁõ : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Pre-Eclampsia Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
°Ç¼º°¢°á¸·¿°(¾È±¸°ÇÁ¶Áõ) : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Keratoconjunctivitis Sicca (Dry Eye) Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
±äÀåÇü µÎÅë : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Tension -Type Headache Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
ºÀ¿ÍÁ÷¿° : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Cellulitis Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
¼¼°èÀÇ ÀÓ»ó½ÃÇè ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м®(2021-2028³â) : »ó(Phase I, Phase II, Phase III, Phase IV), ¿¬±¸ ¼³°è(ÁßÀç, °üÂû, È®ÀåµÈ Á¢±Ù), ÀûÀÀÁõ, Áö¿ªº°
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, By Region, And Segment Forecasts, 2021 - 2028
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 5,950 £Ü 6,791,000
½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
¼¼ÀÚ¸® ÁõÈıº : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2021³â »ó¹Ý±â)
Sezary Syndrome - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
ÆÄºê¸®º´ : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2020³â ÇϹݱâ)
Fabry Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
Á°ñ½Å°æÅë : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä
Sciatica (Sciatic Pain) Disease - Global Clinical Trials Review, H1, 2021
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
½ÃÀå ½ºÆ÷Æ®¶óÀÌÆ® : ÀڱþÏ
Market Spotlight: Uterine Cancer
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 1,318 £Ü 1,504,000
ÀÓ»ó½ÃÇè °ü¸® ½Ã½ºÅÛ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2021-2027³â)
Clinical Trial Management System Market with COVID-19 Impact Analysis, By Type, By Product, By Delivery, By End User, and By Region - Size, Share, & Forecast from 2021-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 3,250 £Ü 3,709,000
ÀÓ»ó½ÃÇè ½ÃÀå : ´Ü°è, ¿¬±¸ ¼³°è, ÀûÀÀÁõ, Áö¿ªº° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø - COVID-19¿¡ ÀÇÇÑ ¿µÇ⠺м®(2021-2027³â)
Clinical Trials Market with COVID-19 Impact Analysis, By Phase, By Study Design, By Indication, and By Region - Size, Share, & Forecast from 2021-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 3,250 £Ü 3,709,000
°¡Á·¼º °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ(IIÇü °í¸®Æ÷´Ü¹éÇ÷Áõ) : ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(-2030³â)
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)- Market Insight, Epidemiology and Market Forecast -2030
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 6,950 £Ü 7,932,000
±¸Åä : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2020³â ÇϹݱâ)
Emesis (Vomiting) Disease - Global Clinical Trials Review, H2, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
ÇǺο°(½ÀÁø) : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2020³â ÇϹݱâ)
Dermatitis (Eczema) Disease - Global Clinical Trials Review, H2, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
¼¶¸Á : ¼¼°è ÀÓ»ó½ÃÇè ¸®ºä(2020³â Èıâ)
Delirium Disease - Global Clinical Trials Review, H2, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,500 £Ü 2,853,000
±Ý¿¬ Ä¡·á : ½ÃÀå ºÐ¼®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(-2030³â)
Smoking Cessation-Market Insights, Epidemiology, and Market Forecast-2030
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 6,950 £Ü 7,932,000
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 koreainfo@gii.co.jp
¨Ï Copyright Global Information, Inc. All rights reserved.